<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
    <title>海洋之心 - 房颤</title>
    <link>https://heart.lihaiyang.com</link>
    <description>心血管文献检索平台 - 最新收录论文</description>
    <language>zh-CN</language>
    <atom:link href="https://heart.lihaiyang.com/rss.php?category=%E6%88%BF%E9%A2%A4" rel="self" type="application/rss+xml"/>
        <item>
        <title>Predicting Recurrence and Outcomes After Stressor-Associated Atrial Fibrillation Using ECG-Based Deep Learning.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=188</link>
        <description>Stressor-associated atrial fibrillation (AF) refers to new-onset AF that occurs with a reversible, acute stressor. Identifying individuals at highest risk for AF recurrence is essential to guide management. Although clinical factors have shown limited value, the utility of contemporary artificial in</description>
        <pubDate>Fri, 20 Mar 2026 00:00:00 +0800</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1161/JAHA.125.047146</guid>    </item>
        <item>
        <title>Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=177</link>
        <description>We investigated the role of Lgi3-4 proteins in cardiac electrophysiology, with a specific focus on IKur, and their potential contribution to the pathophysiology of atrial fibrillation (AF). In human atrial tissue and heterologous cells, Lgi3 and Lgi4 interacted with KV1.5 channels. In a mouse model </description>
        <pubDate>Thu, 19 Mar 2026 00:00:00 +0800</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1093/cvr/cvag049</guid>    </item>
        <item>
        <title>Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=176</link>
        <description>Catheter-based closure of the left atrial appendage is an alternative to oral anticoagulation for stroke prevention in patients with atrial fibrillation. The effectiveness of this strategy, as compared with physician-directed best medical care, in patients at high risk for stroke and bleeding is unk</description>
        <pubDate>Wed, 18 Mar 2026 00:00:00 +0800</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1056/NEJMoa2513310</guid>    </item>
        <item>
        <title>Sex-Based Differences in Atrial Fibrillation: Epidemiology, Prehospital Care, Hospital Management, and Outcomes.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=28688</link>
        <description>BACKGROUND: Atrial fibrillation is a leading cause of emergency medical services (EMS) use, but sex differences across prehospital, hospital, and postdischarge care remain poorly characterized. METHODS: We performed a population-based linked cohort study of adults attended by EMS for atrial fibrilla</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1161/JAHA.125.046016</guid>    </item>
        <item>
        <title>Bleeding-related quality of life in older adults: Psychometric evaluation of the HEmorrhage Life Impact indeX (HELIX).</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=10529</link>
        <description>BACKGROUND: Older adults treated with anticoagulants for atrial fibrillation (AF) or venous thromboembolism (VTE) face heightened bleeding risk, which can affect physical, emotional and social wellbeing and function. Existing instruments assess treatment satisfaction or generic quality of life but d</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1016/j.thromres.2026.109726</guid>    </item>
        <item>
        <title>Osteopontin in Atrial Fibrillation and Atrial Remodeling.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=11328</link>
        <description>Atrial fibrillation is the most prevalent sustained cardiac arrhythmia, characterized by limited therapeutic options because of incompletely understood mechanisms of its development. The key underlying pathogenetic mechanisms involve atrial myocardial inflammation and fibrosis in response to pressur</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1161/JAHA.125.048418</guid>    </item>
        <item>
        <title>Genetic Investigation of Corrected QT Interval Sensitivity to Oral Bepridil Hydrochloride Hydrate in Patients With Atrial Fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=11329</link>
        <description>BACKGROUND: Bepridil is an antiarrhythmic drug used to treat paroxysmal atrial fibrillation; however, its use is limited by corrected QT interval (QTc) prolongation and the risk of ventricular arrhythmias. This study aimed to identify genetic variants associated with bepridil-associated QTc prolonga</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1161/JAHA.125.047046</guid>    </item>
        <item>
        <title>Increased risk of atrial fibrillation and flutter in patients with Cushing's syndrome: a population-based matched cohort study.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=1861</link>
        <description>BACKGROUND: Patients with Cushing's syndrome (CS) have a high prevalence of cardiovascular disease, and other recognized risk factors for atrial fibrillation/flutter (AF/AFL); however, the prevalence of AF/AFL has not been well characterized in this population. METHODS: We conducted a retrospective </description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1093/ejendo/lvag094</guid>    </item>
        <item>
        <title>Clinical Assessment of Thromboembolic Risk in Patients Undergoing Elective Electrical Cardioversion with or Without Transesophageal Echocardiography: A Real-World Observational Study.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=659</link>
        <description>Background and Objectives: Elective electrical cardioversion (eECV) in patients with atrial fibrillation (AF) or atrial flutter is associated with a low risk of thromboembolic events (TEs) when adequate anticoagulation is provided. However, the role of routine transesophageal echocardiography (TEE) </description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.3390/medicina62050970</guid>    </item>
        <item>
        <title>Beyond the Maze: Hybrid Ablation and Left Atrial Appendage Occlusion in Cardiac Surgery: Evidence Synthesis and the MESAGE Study Protocol.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=660</link>
        <description>Background and Objectives: Atrial fibrillation (AF) is the most common cardiac arrhythmia, present in up to 14-20% of patients undergoing cardiac surgery, with the number of patients expected to double within the next decade. Despite a Class I recommendation for concomitant surgical ablation and a C</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.3390/medicina62050890</guid>    </item>
        <item>
        <title>Effects of Diazepam Addition to Standard Treatment of Atrial Fibrillation in Emergency Department Settings: A Unicentric Retrospective Study.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=661</link>
        <description>Background and Objectives: Diazepam, a GABAA receptor agonist with sympatholytic properties, is sometimes co-administered with antiarrhythmic agents in the emergency management of atrial fibrillation (AF), yet evidence supporting this practice is remarkably limited. Given the established role of sym</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.3390/medicina62050861</guid>    </item>
        <item>
        <title>Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=662</link>
        <description>Atrial fibrillation (AF) and heart failure (HF) synergistically interact to exacerbate each other. However, treatment of one entity can greatly improve management of the other. Although historically, permissive medical therapy was the mainstay of AF management in the HF population, recent data stron</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1016/j.ccep.2026.03.001</guid>    </item>
        <item>
        <title>Direct Oral Anticoagulants, COX-2-Selective NSAIDs, and Gastrointestinal Bleeding in Atrial Fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=663</link>
        <description>IMPORTANCE: It is unclear whether the beneficial effects of nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit cyclooxygenase 2 (COX-2) in decreasing the risk of gastrointestinal (GI) bleeding are retained in patients with nonvalvular atrial fibrillation (NVAF) concomitantly trea</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1001/jamanetworkopen.2026.13941</guid>    </item>
        <item>
        <title>The oblique vein of the left atrium: an overlooked vein in anatomical education with emerging clinical importance in atrial fibrillation ablation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=664</link>
        <description>The oblique vein of the left atrium (Vein of Marshall) is frequently underemphasized in anatomical education and classical texts, often regarded as a minor or vestigial structure. However, contemporary electrophysiological practice has revealed its significant role in the pathophysiology and ablatio</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1007/s00276-026-03903-0</guid>    </item>
        <item>
        <title>Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=665</link>
        <description>BACKGROUND: Prior analyses of trials comparing direct oral anticoagulants (DOACs) to warfarin in atrial fibrillation (AF) have not routinely incorporated patient preferences, despite substantial variation in how patients value the trade-off between outcomes such as stroke and bleeding. By applying p</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1056/EVIDoa2500323</guid>    </item>
        <item>
        <title>RT-AFNet: A Hybrid ResNet-Transformer Architecture with Multi-Scale Fusion for Atrial Fibrillation Detection.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=666</link>
        <description>Atrial fibrillation (AF) is a prevalent cardiac arrhythmia associated with an elevated risk of severe complications, including stroke and heart failure. Due to its paroxysmal nature and the inherent complexity of electrocardiogram (ECG) signals, developing highly accurate and robust automated detect</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.3390/bios16050275</guid>    </item>
        <item>
        <title>Prevalence and Associated Factors of Frailty in Middle-Aged and Elderly Patients with Atrial Fibrillation: An Exploratory Machine Learning Analysis.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=667</link>
        <description>BACKGROUND: Frailty significantly increases the risk of adverse outcomes in patients with atrial fibrillation (AF), particularly among middle-aged and elderly individuals. Despite its clinical importance, there is a lack of efficient, multidimensional identification tools specifically tailored for t</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.2147/CIA.S593644</guid>    </item>
        <item>
        <title>Progressive reduction in complications of cryoballoon pulmonary vein isolation for atrial fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=22688</link>
        <description>AIMS: Cryoballoon pulmonary vein isolation (CB-PVI) has become an established treatment for atrial fibrillation and, recently, it has been proposed as first-line therapy for the treatment of paroxysmal atrial fibrillation. Nevertheless, some concerns remain regarding the safety of this thermal energ</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.2459/JCM.0000000000001886</guid>    </item>
        <item>
        <title>Glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes and atrial fibrillation: a multicenter comparative effectiveness cohort study of cardiovascular and arrhythmic outcomes.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=8147</link>
        <description>AIMS: To compare glucagon-like peptide-1 receptor agonists (GLP-1RA) with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) for cardiovascular, atrial fibrillation (AF) disease course, and safety outcomes in adults with concurrent AF and type 2 diabetes. METHODS: Retrospective propensity-score-mat</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1016/j.diabres.2026.113346</guid>    </item>
        <item>
        <title>Convergent Hybrid Ablation Versus Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure: HALT AF Study Protocol and Rationale for a Multicenter Randomized Controlled Trial.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=7143</link>
        <description>BACKGROUND: The coexistence of persistent atrial fibrillation (AF) and heart failure with reduced left ventricular ejection fraction is associated with greater morbidity and death than either condition alone. Catheter ablation improves outcomes in selected patients, yet results in persistent AF rema</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1161/JAHA.125.047774</guid>    </item>
        <item>
        <title>Stopping Oral Anticoagulation After Catheter Ablation for Atrial Fibrillation in Patients With High Risk of Stroke: STOP-OAC Study.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=50684</link>
        <description>BACKGROUND: The benefit of continuing oral anticoagulation (OAC) after catheter ablation (CA) for atrial fibrillation (AF) in patients with a high risk of stroke remains unclear. The Safeness or Threat Of Pausing-Oral anticoagulant therapy After Catheter ablation for atrial fibrillation study (STOP-</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1161/JAHA.126.050952</guid>    </item>
        <item>
        <title>Haemolysis and renal effects across pulsed field ablation systems in atrial fibrillation.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=50687</link>
        <description>AIMS: Pulsed field ablation (PFA) is a non-thermal energy modality for ablation of atrial fibrillation (AF). Although PFA has demonstrated an excellent overall safety profile, increasing evidence suggests an association with intravascular haemolysis, and acute kidney injury (AKI). However, the exten</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>房颤</category>
        <guid>https://doi.org/10.1093/europace/euag190</guid>    </item>
    </channel>
</rss>
